News
Contact Us

News

NEWS CENTER

Home > News

News

sdm News

2025-05-26

SDM Bioservices Concludes A Successful Presence at DIA China 2025 | Exploring Next-Gen Clinical Development Trends

As a clinical development pioneer with twenty years of China-focused expertise, SDM Bioservices provides comprehensive clinical research solutions to pharmaceutical partners worldwide. Our integrated capabilities include proven regulatory submission experience across China, U.S. and EU markets, innovative early-phase development approaches, reliable bioanalytical services, and demonstrated expertise in managing large-scale clinical trials for therapeutic drugs, and specialized knowledge in vaccines and medical aesthetics.

MORE >
2025-05-20

BaoPharm’s Recombinant Human Hyaluronidase HYSORPTASE Successfully Files FDA DMF | SDM Bioservices Supports Key Regulatory Milestone

As BaoPharm's strategic regulatory partner, SDM Bioservices' global registration team delivered comprehensive support for this project, including gap analysis, technical dossier compilation, and submission management services.

MORE >
2025-04-23

SDM Bioservices supports Kygent in securing FDA Orphan Drug Designation for KY-001

KY-001 is an oral small-molecule inhibitor targeting the YAP/TAZ-TEAD interaction in the Hippo pathway with a proposed indication for advanced solid tumors driven by Hippo dysregulation.

MORE >
2025-03-14

Interview | Dr. Shen Liping: We are not only supporters of vaccine development but also drivers of industry innovation

Listen to Dr. Liping Shen: Innovating Vaccine Bioanalysis for Change

MORE >
2025-02-25

SDM Bioservices Supports Meiji in Successful FDA Clinical Trial Application for MJC-001, the World’s First Oral Paclitaxel Softgel Capsule

Meiji has advanced its oral paclitaxel softgel capsule, MJC-001, to clinical trial stage. With support from SDM Bioservices, Meiji received FDA clearance for its Investigational New Drug (IND) application, positioning it among the leading developers of oral paclitaxel formulations.

MORE >
First Name
Last Name
Email
Company
Title
Submit
Reject All
Accept All